LTR 89: Navigating uncertain times at the FDA
Let's Talk Risk! with Dr. Naveen Agarwal · Casual and informal conversations about practical aspects of medical device risk management.
February 12, 20251m 52s
Audio is streamed directly from the publisher (api.substack.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This is a free preview of a paid episode. To hear more, visit naveenagarwalphd.substack.com
Summary
“For the foreseeable future, core FDA practices such a reviewing submissions and post-market oversight are going to continue. Smart Money says FDA in 6 months or an year from now, as to these core responsibilities, is operating similarly to FDA of mid-2024.”
Yes, there is a lot of uncertainty due to the current political environment in the USA, a…